Across KRASm isoforms of non-Sq NSCLC, 46–51% harbored TP53, 5.1–9.2% TP53/STK11 and 1.3–2.6% TP53/STK11/KEAP1 co-alterations (Supplemental Fig. 8). Here, STK11 is linked to non-small cell lung carcinoma.